Scientists discover compounds that help cells fight a wide range of viruses
On Jul. 14, 2025, Researchers at MIT and other institutions have identified compounds that can fight off viral…
-
-
Northwestern scientists studied 174 brain samples. CTE and aging were difficult to distinguish
On Jul. 11, 2025, findings from Northwestern University study show the brain protein tied to CTE is not…
-
UCLA study identifies key protein that helps liver cancer resist heat-based treatment
On Jul. 10, 2025, a study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may…
-
A bionic knee integrated into tissue can restore natural movement
On Jul. 10, 2025, MIT researchers announced they have developed a new bionic knee that can help people…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
FDA approves updated label for Lilly’s Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer’s disease
On Jul. 9, 2025, Eli Lilly announced that the U.S. Food and Drug Administration (FDA) has approved a…
-
Biotechnology | Disease | FDA | Therapeutics
Merck spends $10 billion for Verona, gaining access to its COPD medication
On Jul. 9, 2025, pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases,…
-
Major autism study uncovers biologically distinct subtypes, paving the way for precision diagnosis and care
On Jul. 9, 2025, researchers at Princeton University and the Simons Foundation have identified four clinically and biologically…
-
Implantable device could save diabetes patients from dangerously low blood sugar
On Jul. 9, 2025, MIT engineers announced they have designed an implantable reservoir that can remain under the…
-
Experimental Compound Offers Potential Treatment for Rare, Often Fatal, Childhood Disease
On Jul. 9, 2025, as part of a new study, neurologists at NYU Langone Health announced they have…
-
Cognitive impairment Found 2 years after mild to severe SARS-CoV-2 infection
On Jul. 8, 2025, a study published in Nature showed the prevalence of cognitive impairment 2 years after…
-
Chan Zuckerberg Initiative, Innovative Genomics Institute Announce New Center for Pediatric CRISPR Cures
On Jul. 8, 2025, the Chan Zuckerberg Initiative (CZI) and the Innovative Genomics Institute (IGI) announced the funding of the…
-
Scientists create biological ‘artificial intelligence’ system
On Jul. 7, 2025, Australian scientists, including at the Charles Perkins Centre, University of Sydney, have successfully developed…
-
Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)
On Jul. 7, 2025, Celltrion announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimilars referencing PROLIA® (denosumab) and XGEVA® (denosumab)…
-
KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for Hereditary Angioedema
On Jul. 7, 2025, KalVista Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has approved EKTERLY® (sebetralstat),…
-
WHO Releases guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
On Jul. 4, 2025, the World Health Organization (WHO) released the Integrated Guidelines on the Clinical Management of…
-
Scientists create first mini-lungs with built-in blood vessels, unlocking new insights for pulmonary vascular disease
On Jul. 2, 2025, researchers from the University of California, Los Angeles (UCLA) announced they have successfully grown…
-
AbbVie to Acquire Capstan Therapeutics for $2.1 billion
On Jun. 30, 2025, AbbVie and Capstan Therapeutics announced a definitive agreement under which AbbVie will acquire Capstan,…
-
Precision gene editing medicine makes history, and it’s just getting started
On Jun. 30, 2025, as in something out of science fiction, a team of researchers reached into the…
-
Parkinson’s drug effective in treating persistent depression
On Jun. 30, 2025, a University of Oxford led study reported that a drug used for Parkinson’s disease…
-
Calgary reintroduces fluoride into drinking water
On Jun. 30, 2025, Fluoride was reintroduced into the drinking water in Alberta’s largest city nearly four years…
-
Scientists discover network of cells and genes involved in Crohn’s disease complication
On Jun. 30, 2025, the Broad Institute announced that spatial mapping reveals genes contributing to fibrosis, or scarring,…
-
World Microbiome Day Celebrated
On Jun. 27, 2025, today is World Microbiome Day and the Microbiota Vault, together with all participating Local…
-
Researchers take first steps to creating synthetic human genomes
On Jun. 26, 2025, a team of UK-based scientists announced they are developing technology to create the first…
-
Google DeepMind Announce AlphaGenome: AI for better understanding the genome
On Jun. 25, 2025, Google Deepmind introduced AlphaGenome, a new artificial intelligence (AI) tool that more comprehensively and…
-
Agriculture | Biotechnology | Clinical Research | Cloning | COVID-19 | Diagnostics | FDA | Genomics | Infectious Disease | Marine Science | Medical Device | NIH | Non-Profit Research | Oncology | Stem Cell | Therapeutics | U.S. Congress | USDA | Vaccine | Veterinary | Women's Health
NIH will reinstate 900 grants in response to court order
On Jun. 25, 2025, the National Institutes of Health (NIH) moved to reinstate about 900 grants that a…
-
CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults overweight or obesity in REDEFINE 1, published in NEJM
On Jun. 22, 2025, The New England Journal of Medicine (NEJM) published results from Novo Nordisk’s phase 3…
-
Biotechnology | Disease | FDA | Medicine | Therapeutics
Dupixent approved in the U.S. as the only targeted medicine to treat patients with bullous pemphigoid
On Jun. 20, 2025, the US Food and Drug Administration (FDA) announced it has approved Dupixent (dupilumab) for…
-
Vertex Reports Positive Data for Zimislecel in Type 1 Diabetes
On Jun. 20, 2025, Vertex Pharmaceuticals announced publication of updated data from the Phase 1/2 portion of the…
-
Biotechnology | CDC | FDA | HIV | Infectious Disease | Medicine | Therapeutics
Yeztugo® (Lenacapavir) Is the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection
On Jun. 18, 2025, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo®…
-
Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery
On Jun. 18, 2025, SandboxAQ, an artificial intelligence startup spun out of Alphabet’s Google and backed by Nvidia…
